drugset / Trial / NCT02562612
Study of SM-88 in Advanced Cancers
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to collect response and pharmacokinetic data on the oral administration of a cocktail combination of 4 drugs being developed for the indication of metastatic breast cancer.
Timeline
- Start
- 2022-10
- Primary completion
- 2023-10
- Completion
- 2023-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SM-88 | Unknown | — | Oral |